Tomorrow, Sellas Life Sciences will be presenting data at the San Antonio Breast Cancer Symposium, the same exact meeting that proved to be the ...
News
- SLS Stock: Here's Why Sellas Life Sciences Is Climbing
- Gilead to acquire German biotech firm MYR for about 1.15 billion euros
(Bloomberg) -- Greenwich LifeSciences Inc., the biotech firm that soared ... Sellas is set to present data on Friday at the San Antonio Breast Cancer ...
- Tiny Biotechs Extend Wild Rides as Day Traders Chase Booms
Greenwich LifeSciences Inc., the biotech firm that soared 998% on ... Sellas is set to present data on Friday at the San Antonio Breast Cancer ...
- The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 ...
San Antonio Breast Cancer Symposium Presentations. G1 Therapeutics Inc (NASDAQ: GTHX) said final data from its randomized Phase 2 trial of ...
- Covid-19 roundup: UAE claims Sinopharm vaccine 86% effective, but details are scant; India ...
Both the Serum institute and Bharat Biotech have been asked for more data, according to NDTV. Over in the UK, regulators have said they'll review all ...